- Merit Medical is benefiting from a strong rebound in hospital procedures, and the company isn't as vulnerable to others from the recent surge in COVID-19 infections and hospitalizations.
- New product leverage and margin self-help remain important drivers, with SCOUT performing well and WRAPSODY data coming soon, while gross margin improvement efforts are currently challenged by input cost inflation.
- Healthy mid-single-digit revenue growth and mid-20%'s EBITDA margins can support a 4x forward revenue multiple, or a fair value close to $80.
For further details see:
Merit Medical: Nothing Flashy, But Solid Execution Supports The Story